Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
12 April - 6 June 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP study conducted according to OECD Guideline 471 with minor deviation: temperature of the incubator rose to 38.1 °C overnight, just above the 37 ± 1 °C limit
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
temperature of the incubator rose to 38.1 °C overnight, just above the 37 ± 1 °C limit
Principles of method if other than guideline:
Not applicable
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
(1r,4r)-1-methyl-4-(propan-2-yl)cyclohexyl acetate; (1s,4s)-1-methyl-4-(propan-2-yl)cyclohexyl acetate; 2-[(1r,4r)-4-methylcyclohexyl]propan-2-yl acetate; 2-[(1s,4s)-4-methylcyclohexyl]propan-2-yl acetate
EC Number:
939-728-7
Molecular formula:
C12H22O2
IUPAC Name:
(1r,4r)-1-methyl-4-(propan-2-yl)cyclohexyl acetate; (1s,4s)-1-methyl-4-(propan-2-yl)cyclohexyl acetate; 2-[(1r,4r)-4-methylcyclohexyl]propan-2-yl acetate; 2-[(1s,4s)-4-methylcyclohexyl]propan-2-yl acetate
Test material form:
gas under pressure: refrigerated liquefied gas
Details on test material:
- Name of test material (as cited in study report): Menthanyl acetate multiconstituent
- Physical state: Colourless to slightly amber liquid
- Analytical purity: 98.3 %
- Lot/batch No.: 110996
- Date of receipt: 21 February 2012
- Expiration date of the lot/batch: 9 September 2012
- Storage condition of test material: Stored at 2-8 °C, protected from light and under nitrogen

Method

Target gene:
Histidine gene
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
other: All strains were checked for characteristics (histidine dependence, rfa character, uvrB character and resistance to ampicillin or ampicillin plus tetracycline).
Metabolic activation:
with and without
Metabolic activation system:
10 % S9 mix; S9 fraction prepared from liver homogenates of male Sprague Dawley rats induced with Aroclor 1254
Test concentrations with justification for top dose:
Mutagenicity tests:
- Experiment 1: 5, 15.81, 50, 158.1, 500, 1581 and 5000 μg/plate, with and without S9 mix in all 5 strains (plate incorporation method)
- Experiment 2a: 1.563, 3.125, 6.25, 12.5, 25, 50 and 100 μg/plate, without S9 mix in strains TA100 and TA1535 (plate incorporation method)
- Experiment 2b: 4.096, 10.24, 25.6, 64, 160 and 400 μg/plate; strains TA 98, TA 1537 and TA 102 in the absence (plate incorporation method) and presence of S9 (preincubation method) and strains TA 100 and TA 1535 in the presence of S9 (preincubation method) [1.638 μg/plate used in strains TA98 and TA1537 in the absence of S9 and strain TA102 in the presence of S9 only; 1000 μg/plate used in strain TA 102 in the absence of S9 and strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 only]
- Experiment 3: 1.563, 3.125, 6.25, 12.5, 25, 50 and 100 μg/plate, with S9 mix in strain TA1537 (preincubation method)
- Experiment 4: 1.563, 3.125, 6.25, 12.5, 25 and 50 μg/plate, with S9 mix in strains TA 1535, TA 98, TA 100 and TA 102 (preincubation method) [0.7813 μg/plate used in strain TA 102; 100 μg/plate used in strains TA 98, TA 100 and TA 1535]
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Ethanol
Formulation procedure:
- Test article stock solutions were prepared by formulating Menthanyl acetate multiconstituent in ethanol under subdued lighting conditions with the aid of vortex mixing and warming to 30 °C as required, immediately prior to assay to give the maximum required treatment solution concentration. Subsequent dilutions were made using ethanol. The test article solutions were protected from light and used within approximately 5.5 h of initial formulation.

Volume addition: 0.1 mL volume additions of vehicle/test article solution were used for all plate-incorporation treatments, 0.05 mL volume additions of vehicle/test article solution were used for pre-incubation treatments.
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
Ethanol
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
mitomycin C
Remarks:
without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
Ethanol
True negative controls:
no
Positive controls:
yes
Positive control substance:
benzo(a)pyrene
other: 2- Aminoanthracene
Remarks:
with metabolic activation
Details on test system and experimental conditions:
SOURCE OF TEST SYSTEM: Strains TA 98, TA 1535 and TA 1537 were originally obtained from the UK NCTC. Strains TA 100 and TA 102 were derived from cultures originally obtained from Covance Laboratories Inc., USA.

METHOD OF APPLICATION: In agar (plate incorporation and preincubation method)

DURATION
- Preincubation period: 20 minutes at 37 ± 1 °C
- Incubation period: Plates were inverted and incubated at 37 ± 1 °C in the dark for 3 days.

NUMBER OF REPLICATIONS:
- Treatment and positive control groups: 3 plates/dose
- Vehicle control group: 5 plates/dose

DETERMINATION OF CYTOTOXICITY
- Method: Background lawn was inspected for signs of toxicity.

OTHER:
Colony counting: Colonies were counted electronically using a Sorcerer Colony Counter (Perceptive Instruments) or manually where confounding factors such as bubbles or splits in the agar affected the accuracy of the automated counter.
Evaluation criteria:
- For valid data, the test article was considered to be mutagenic if:
1. When assessed using Dunnett's test, an increase in revertant numbers gave a significant response (p ≤ 0.01) which was concentration related.
2. The positive trend/effects described above were reproducible.
- Test article was considered positive in this assay if all of the above criteria were met.
- Test article was considered negative in this assay if none of the above criteria were met.

- Results which only partially satisfied the above criteria were dealt with on a case-by-case basis. Biological relevance was taken into account, for example consistency of response within and between concentrations and (where applicable) between experiments.
Statistics:
- Dunnett's test was used to compare the counts at each concentration with the control. The presence or otherwise of a concentration response was checked by non-statistical analysis, up to limiting levels (for example toxicity, precipitation or 5000 μg/plate).

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
COMPARISON WITH HISTORICAL CONTROL DATA: Mean vehicle control counts fell within the normal historical ranges (historical control data of February 2008 - July 2009).

ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Experiment 1: Toxicity was observed at concentrations of 50 μg/plate and above in strains TA 100 and TA 1535 in the absence of S9; 158.1 μg/plate and above in strains TA 98 and TA 1537 in the absence of S9 and strain TA 102 in the presence of S9; and 500 μg/plate and above in strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 and strain TA 102 in the absence of S9.
- Experiment 2: Toxicity was observed at 1000 μg/plate in strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 and TA 102 in the absence of S9; 400 μg/plate in strains TA 98 and TA 1537 in the absence of S9 and strain TA 102 in the presence of S9; and 100 μg/plate in strains TA 100 and TA 1535 in the absence of S9. Toxicity was observed at concentrations of 10.24 and/or 25.6 μg/plate and above in all strains in the presence of S9; 50 μg/plate and above in strain TA 100 in the absence of S9, 64 μg/plate and above in strain TA 98 in the absence of S9, 100 μg/plate and above in strain TA 1535 in the absence of S9, and 160 μg/plate and above in strains TA 1537 and TA 102 in the absence of S9.
- Experiment 3 and 4: Toxicity was observed at concentrations of 25 μg/plate and above in all strains.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 7.6.1/2: Results of mutagenicity

Group

Concentration (µg/plate)

Mean revertant numbers/plate

Concentration (µg/plate)

Mean revertant numbers/plate

Experiment 1

Experiment 2

TA 98 -S-9

Ethanol

 

27.6

 

26.8

Test item

5

26.7

1.638

18.7

15.81

27.3

4.096

28.7

50

28.3

10.24

27.7

158.1

27.7

25.6

22.3

500

30.0

64

33.0

1581

25.0

160

22.7

5000

16.3

400

28.7

2NF

5

1070.3

5

1134.3

TA 98 +S-9

Ethanol

 

37.8

 

32.0

Test item

5

29.0

4.096

30.7

15.81

32.3

10.24

25.0

50

32.0

25.6

31.0

158.1

36.7

64

17.0

500

34.0

160

30.7

1581

32.7

400

25.7

5000

19.3

1000

23.7

B[a]P

10

440.3

10

548.7

TA 100 -S-9

Ethanol

 

93.2

 

87.2

Test item

5

82.0

1.563

94.3

15.81

111.7*

3.125

93.7

50

92.7

6.25

72.7

158.1

76.0

12.5

85.7

500

69.3

25

77.0

1581

49.0

50

92.7

5000

26.0

100

53.7

NaN3

2

690.3

2

789.0

TA 100 +S-9

Ethanol

 

105.0

 

98.4

Test item

5

119.7

4.096

91.0

15.81

106.0

10.24

80.7

50

86.0

25.6

75.3

158.1

100.3

64

58.0

500

85.3

160

68.0

1581

27.0

400

72.7

5000

T

1000

56.7

AAN

5

1443.0

5

1139.7

TA 1535 -S-9

Ethanol

 

21.8

 

17.8

Test item

5

22.0

1.563

15.3

15.81

20.3

3.125

11.3

50

21.0

6.25

15.0

158.1

12.0

12.5

14.7

500

10.0

25

15.3

1581

9.0

50

15.7

5000

8.0

100

15.0

NaN3

2

690.7

2

653.0

TA 1535 +S-9

Ethanol

 

22.6

 

17.4

Test item

5

22.0

4.096

15.3

15.81

27.3

10.24

20.7

50

25.0

25.6

18.0

158.1

36.7

64

13.0

500

21.3

160

11.7

1581

17.7

400

8.3

5000

15.0

1000

9.3

AAN

5

251.3

5

193.3

TA 1537 -S-9

Ethanol

 

8.2

 

8.4

Test item

5

8.3

1.638

5.3

15.81

11.0

4.096

6.3

50

8.0

10.24

6.3

158.1

8.0

25.6

6.7

500

6.3

64

5.7

1581

T

160

7.3

5000

T

400

3.3

AAC

50

183.3

50

126.7

TA 1537 +S-9

Ethanol

 

19.8

 

14.2

Test item

5

17.7

4.096

20.7

15.81

20.0

10.24

6.0

50

15.7

25.6

12.3

158.1

17.7

64

T

500

14.7

160

T

1581

T

400

T

5000

T

1000

T

AAN

5

294.3

5

120.3

TA 102 -S-9

Ethanol

 

246.2

 

246.8

Test item

5

267.7

4.096

216.0

15.81

261.7

10.24

220.3

50

217.0

25.6

231.3

158.1

196.0

64

232.0

500

198.0

160

196.3

1581

200.0

400

155.0

5000

200.3

1000

107.3

MMC

0.2

875.3

0.2

962.3

TA 102 +S-9

Ethanol

 

251.0

 

215.0

Test item

5

264.3

1.638

250.0

15.81

248.0

4.096

256.7

50

244.3

10.24

190.3

158.1

199.7

25.6

182.0

500

195.7

64

92.3

1581

264.0

160

105.7

5000

243.7

400

131.3

AAN

20

1751.0

20

1134.3

Experiment 3 (TA 1537 +S-9)

Experiment 4 (TA 98 +S-9)

Ethanol

 

16.4

 

36.0

Test item

1.563

14.7

1.563

38.0

3.125

7.7

3.125

30.7

6.25

15.3

6.25

25.7

12.5

9.3

12.5

29.3

25

11.3

25

22.3

50

T

50

27.3

100

T

100

T

AAN

5

178.0

B[a]P 10

455.7

Experiment 4 (TA 100 +S-9)

Experiment 4 (TA 1535 +S-9)

Ethanol

 

108.2

 

16.6

Test item

1.563

96.7

1.563

16.3

3.125

93.7

3.125

16.0

6.25

99.7

6.25

20.7

12.5

115.7

12.5

14.0

25

91.7

25

7.7

50

77.0

50

12.0

100

T

100

12.0

AAN

5

901.0

AAN 5

197.0

Experiment 4 (TA 102 +S-9)

Ethanol

 

195.4

NA

Test item

0.7813

162.7

1.563

154.3

3.125

148.3

6.25

129.7

12.5

140.3

25

128.7

50

112.3

AAN

20

901.0

T: Toxic, no revertant colonies; * p ≤ 0.05

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

Under the test conditions, Menthanyl acetate multiconstituent is not considered as mutagenic in S. typhimurium strains (TA 1535, TA 1537, TA 98, TA 100 and TA 102).
Executive summary:

In a reverse gene mutation assay in bacteria, performed according to the OECD Guideline 471 and in compliance with GLP, strains of Salmonella typhimurium (TA 1535, TA 1537, TA 98, TA 100 and TA 102) were exposed to Menthanyl acetate multiconstituent at the following concentrations:

- Experiment 1: 5, 15.81, 50, 158.1, 500, 1581 and 5000 μg/plate, with and without S9 mix in all 5 strains (plate incorporation method)

- Experiment 2a: 1.563, 3.125, 6.25, 12.5, 25, 50 and 100 μg/plate, without S9 mix in strains TA100 and TA1535 (plate incorporation method)

- Experiment 2b: 4.096, 10.24, 25.6, 64, 160 and 400 μg/plate; strains TA 98, TA 1537 and TA 102 in the absence (plate incorporation method) and presence of S9 (preincubation method) and strains TA 100 and TA 1535 in the presence of S9 (preincubation method) [1.638 μg/plate used in strains TA 98 and TA 1537 in the absence of S9 and strain TA102 in the presence of S9 only; 1000 μg/plate used in strain TA 102 in the absence of S9 and strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 only]

- Experiment 3: 1.563, 3.125, 6.25, 12.5, 25, 50 and 100 μg/plate, with S9 mix in strain TA1537 (preincubation method)

- Experiment 4: 1.563, 3.125, 6.25, 12.5, 25 and 50 μg/plate, with S9 mix in strains TA 1535, TA 98, TA 100 and TA 102 (preincubation method) [0.7813 μg/plate used in strain TA 102; 100 μg/plate used in strains TA 98, TA 100 and TA 1535]

Metabolic activation system used in this test was10 % S9 mix. S9 fraction was prepared from liver homogenates of male Sprague Dawley rats induced with Aroclor 1254. Vehicle control and positive control groups were also included in mutagenicity tests.

In experiment 1, toxicity was observed at concentrations of 50 μg/plate and above in strains TA 100 and TA 1535 in the absence of S9; 158.1 μg/plate and above in strains TA 98 and TA 1537 in the absence of S9 and strain TA 102 in the presence of S9; and 500 μg/plate and above in strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 and strain TA 102 in the absence of S9. In Experiment 2, toxicity was observed at 1000 μg/plate in strains TA 98, TA 100, TA 1535 and TA 1537 in the presence of S9 and TA 102 in the absence of S9; 400 μg/plate in strains TA 98 and TA 1537 in the absence of S9 and strain TA 102 in the presence of S9; and 100 μg/plate in strains TA 100 and TA 1535 in the absence of S9. Toxicity was observed at concentrations of 10.24 and/or 25.6 μg/plate and above in all strains in the presence of S9; 50 μg/plate and above in strain TA 100 in the absence of S9, 64 μg/plate and above in strain TA 98 in the absence of S9, 100 μg/plate and above in strain TA 1535 in the absence of S9, and 160 μg/plate and above in strains TA 1537 and TA 102 in the absence of S9. In Experiment 3 and 4, toxicity was observed at concentrations of 25 μg/plate and above in all strains. The positive and vehicle controls induced the appropriate responses in the corresponding strains. Test item did not induce statistically significant increases in revertant colony numbers over control count obtained with any of the tester strains at any concentrations in either presence or absence of metabolic activation.

Under the test conditions, Menthanyl acetate multiconstituent is not considered as mutagenic in this bacterial system.